CroíValve Announces First Implant of a Novel Minimally Invasive Device for Tricuspid Regurgitation in US Early Feasibility Study Read More → October 24, 2024
CroíValve Announces $16 Million Equity Financing to Fund US Early Feasibility Study of Novel Transcatheter Tricuspid Device Read More → August 7, 2024
Positive Six-Month Results from CroíValve’s TANDEM I Study to Treat Tricuspid Regurgitation Presented at New York Valves 2024 Read More → June 10, 2024
CroíValve is set to challenge as tricuspid regurgitation treatment space heats up Read More → April 25, 2024
CroíValve Announces FDA IDE Approval and Initiation of its Early Feasibility Study Read More → January 25, 2024
First in Human Experience with the CroiValve DUO Novel Tricuspid Coaptation Valve: THE TANDEM I Trial Read More → June 9, 2023
Transcatheter tricuspid valve implantation in Medical University of Warsaw – TANDEM I study. Many thanks to Dr Martin Quinn and the entire CroiValve team for excellent support! Read More → May 23, 2023
CroíValve Reports Successful First in Human Implants of its DUO Tricuspid Coaptation Valve System Read More → November 22, 2022
